FRT
41
-2
FMC
36
3
FTI
69
-7
MRK
53
3
CME
56
-3
ABT
57
-9
SWK
80
2
MCHP
42
-5
CI
66
-2
SE
65
4
GOOGL
53
2
EXC
50
-4
PNR
72
-2
BAC
39
-2
STX
53
-4
ETR
68
-3
GD
57
-2
HPQ
62
2
DTE
56
-7
DRI
64
4
FRT
41
-2
FMC
36
3
FTI
69
-7
MRK
53
3
CME
56
-3
ABT
57
-9
SWK
80
2
MCHP
42
-5
CI
66
-2
SE
65
4
GOOGL
53
2
EXC
50
-4
PNR
72
-2
BAC
39
-2
STX
53
-4
ETR
68
-3
GD
57
-2
HPQ
62
2
DTE
56
-7
DRI
64
4
Financhill
Back

Fulcrum Therapeutics Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1

FULC
Fulcrum Therapeutics

Last Price:
3.48
Seasonality Move:
-0.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Fulcrum Therapeutics Price Quote

$3.48
+0.04 (+1.16%)
(Updated: September 19, 2024 at 12:30 PM ET)

Fulcrum Therapeutics Key Stats

Sell
1
Fulcrum Therapeutics (FULC) is a Sell
Day range:
$3.34 - $3.55
52-week range:
$2.87 - $13.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.78%
Volume:
1.4M
Avg. volume:
2.3M
1-year change:
-21.1%
Market cap:
$214.7M
Revenue:
$2.8M
EPS:
$-0.35

How Much Does Fulcrum Therapeutics Make?

Data Unavailable

Is Fulcrum Therapeutics Growing As A Company?

  • What Is Fulcrum Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 89.91%
  • What Is Fulcrum Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Fulcrum Therapeutics Stock Price Performance

What Is Fulcrum Therapeutics 52-Week High & Low?

Fulcrum Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Fulcrum Therapeutics?

Is Fulcrum Therapeutics Cash Flow Positive?

  • What Is FULC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.4M
  • What Is Fulcrum Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.3M
  • What Is Fulcrum Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $63M

Fulcrum Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FULC return on invested capital is -8.07%
  • What Is Fulcrum Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -7.42%
  • What Is FULC Return On Equity?
    ROE is a measure of profitability and is -8.07%

Fulcrum Therapeutics Earnings Date & Stock Price

Fulcrum Therapeutics Competitors

Fulcrum Therapeutics Dividend Yield

Fulcrum Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.63%
Revenue: 8990.91% -100%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 5.29
Upside from Last Price: 53.65%

Major Shareholders

  • How many FULC shares are owned by institutional investors?
    93.5M FULC shares are owned by institutional investors
  • How many FULC shares are owned by insiders?
    1.1M FULC shares are owned by insiders